Q4 2025 GoodRx Holdings Inc Earnings Call Transcript
Key Points
- GoodRx Holdings Inc (GDRX) reported a strong finish to 2025, with revenue from PharmaDirect increasing by over 40% year over year.
- The company expanded its direct-to-consumer affordability programs and deepened relationships with retail pharmacies, enhancing its strategic positioning.
- GoodRx Holdings Inc (GDRX) launched condition-specific subscriptions, which exceeded initial expectations, particularly in areas like weight loss.
- The company maintained a strong balance sheet with $261.8 million in cash and repurchased approximately 48.9 million shares, signaling management's confidence in the company's future.
- GoodRx Holdings Inc (GDRX) is leveraging its position as the #1 prescription app with nearly 300 million site visits annually to drive value in a consumer-driven healthcare environment.
- Prescription transactions revenue declined by 6% year over year, impacted by the Rite Aid bankruptcy and lower volume through integrated savings program partners.
- Subscription revenue decreased by 3% year over year, although new condition-specific subscriptions are expected to contribute more meaningfully in 2026.
- The company faces near-term financial impacts from transitioning its business model, with expected pressure on prescription transactions revenue in 2026.
- Monthly active consumers fell by 14% in 2025 compared to the previous year, indicating challenges in maintaining user engagement.
- GoodRx Holdings Inc (GDRX) is experiencing a reset of unit economics due to negotiations of lower fees across multiple partners, impacting short-term financial performance.
You.
Ladies and gentlemen, thank you for standing by and welcome to the Good Rx 4th quarter in full year 2025 earnings call. As a reminder, today's conference is being recorded. I would like now to introduce your host for today's call, Aubrey Reynolds, director of investor relations. Ms. Reynolds, you may begin.
Thank you, operator. Good morning, everyone, and welcome to GoodRx's earnings conference call for the 4th quarter and full year 2025.
Joining me today are Wendy Barnes, our Chief Executive Officer, and Chris McGinnis, our Chief Financial Officer.
Before we begin, I'd like to remind everyone that this call will contain forward-looking statements.
All statements made on this call that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation, statements regarding management's plans, strategies, goals and objectives, our market opportunity, our anticipated financial
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
